Quest Diagnostics News

MediCheck™ 02-04-2013

In-Home Clinical Risk Assessment for Health Plan Members

Maintaining a high-quality assessment program for your health plan isn’t just about risk adjustment, it’s about the health and satisfaction of your members – and keeping costs under control.

MediCheck™ is a dedicated data collection system for health plans to control the health risk assessment process. By utilizing an industry leading health outreach team, it closes gaps in data collection, health history, member education and reporting. MediCheck removes the guesswork in member health data, enabling greater specificity and clinical substantiation to improve health documentation. Learn more about our innovative risk assessment process at QuestDiagnostics.com.

Download our white paper, or watch the video below to see how MediCheck gets to the source of actionable data.

MediCheck

Contact us at MediCheck@ExamOne.com or 1-855-324-7468.

Read More

Recent Quest Diagnostics Health Trends™ Study Indicates Rise in Diabetes Diagnoses 05-12-2015

May 11, 2015 - A recent Quest Diagnostics study indicated a significant rise in new diabetes cases in states that expanded Medicaid eligibility under the Affordable Care Act. The study reported that in states that expanded Medicaid, newly identified cases of diabetes rose 23 percent, compared to just .4 percent in the states that did not expand the program. Quest’s study was based on results of hemoglobin A1C tests, which reflect long-term glucose in the blood.

ExamOne, a Quest Diagnostics company, provides valuable testing services to health plans and their members, including Medicaid. MediCheck™ is a dedicated data collection system offered by ExamOne that enables health plans to control the health risk assessment process.
The recent Quest study highlights the importance of regular health assessments for health plan members.
“Our study demonstrates the value of objective insights gleaned from aggregate diagnostic data for informing population health strategies that can promote better health outcomes,” said Jay Wohlgemuth, M.D., senior vice president and chief scientific officer – research, development and medical, Quest Diagnostics.
A key finding in the study said that people with diabetes were identified at earlier stages in states that expanded Medicaid. According to the study, Quest scientists found lower hemoglobin A1C levels in newly identified patients in expansion states versus those in non-expansion states.
Early diagnosis and treatment are key to managing chronic health conditions such as diabetes, and can reduce the risk of developing additional health complications. The goal of MediCheck is to assist health plans with the data collection necessary to identify risks, and ultimately provide a plan for members to manage their health. Whether the health risk assessment process uncovers new information or reinforces the existing recommendations of the member’s physician, the documentation of those conditions, along with the face-to-face coaching, can help ensure that health plans are not only HEDIS-ready, but also actively supporting member health.
“Our study demonstrates the value of objective insights gleaned from aggregate diagnostic data for informing population health strategies that can promote better health outcomes,” said Jay Wohlgemuth, M.D., senior vice president and chief scientific officer – research, development and medical, Quest Diagnostics.

A recent Quest Diagnostics study indicated a significant rise in new diabetes cases in states that expanded Medicaid eligibility under the Affordable Care Act. The study reported that in states that expanded Medicaid, newly identified cases of diabetes rose 23 percent, compared to just .4 percent in the states that did not expand the program. Quest’s study was based on results of hemoglobin A1C tests, which reflect long-term glucose in the blood.

ExamOne, a Quest Diagnostics company, provides valuable testing services to health plans and their members, including Medicaid. MediCheck™ is a dedicated data collection system offered by ExamOne that enables health plans to control the health risk assessment process.

The recent Quest study highlights the importance of regular health assessments for health plan members.

A key finding in the study said that people with diabetes were identified at earlier stages in states that expanded Medicaid. According to the study, Quest scientists found lower hemoglobin A1C levels in newly identified patients in expansion states versus those in non-expansion states.

Early diagnosis and treatment are key to managing chronic health conditions such as diabetes, and can reduce the risk of developing additional health complications. The goal of MediCheck is to assist health plans with the data collection necessary to identify risks, and ultimately provide a plan for members to manage their health. Whether the health risk assessment process uncovers new information or reinforces the existing recommendations of the member’s physician, the documentation of those conditions, along with the face-to-face coaching, can help ensure that health plans are not only HEDIS-ready, but also actively supporting member health.

Read More

Inclement Weather - FedEx Update 02-18-2015

February 18, 2015 

Due to to inclement weather in Memphis, FedEx was unable to deliver specimens as scheduled yesterday morning to our Lenexa site.  We had anticipated their arrival yesterday afternoon, but they again were unable to make a delivery.  Specimens arrived on site this morning at 8am and we will process everything as expeditiously as possible.  While we received a large shipment, there are still specimens awaiting transport to Kansas City from Memphis.

Throughout this period of time, FedEx was able to deliver specimens to our St. Louis laboratory and they have been processed as expected.

We appreciate your patience and understanding as we work through these weather-related delays and apologize for any inconvenience this has caused. 

Read More

Inclement Weather - FedEx Update 02-18-2015

February 18, 2015 

Due to to inclement weather in Memphis, FedEx was unable to deliver specimens as scheduled yesterday morning to our Lenexa site.  We had anticipated their arrival yesterday afternoon, but they again were unable to make a delivery.  Specimens arrived on site this morning at 8am and we will process everything as expeditiously as possible.  While we received a large shipment, there are still specimens awaiting transport to Kansas City from Memphis.

Throughout this period of time, FedEx was able to deliver specimens to our St. Louis laboratory and they have been processed as expected.

We appreciate your patience and understanding as we work through these weather-related delays and apologize for any inconvenience this has caused. 

Read More

ExamOne Receives Empowering Better Health Award from Quest Diagnostics 02-10-2015

February 10, 2015 – Today ExamOne received one of Quest’s most prestigious annual awards - the Empowering Better Health Award – in recognition of its innovative consumer health tool, Inside Look® Online. Members of the product, marketing and information technology teams accepted the award on behalf of ExamOne at a special ceremony during the 2015 National Sales Meeting in Dallas.

Empowering Better Health Award

The Empowering Better Health Award honors the technical, clinical and business achievements that contribute to a healthier world. These can be individual or team accomplishments that improve healthcare and support our goal of fostering a healthier world.

To date, more than half a million life insurance applicants have accessed their laboratory test results via Inside Look® Online.

The secure site and patent-pending, consumer-friendly design has received thousands of positive comments from life insurance applicants such as, “The test results were easy to access once I received my password. The diagram is fantastic and very informative. I showed several family members and have not had anything that easy to understand regarding lab results. Thank you for this service and format....excellent!”**

"This tool and these individuals best represent – through their actions and commitment – the words found in our vision statement, empowering better health," said Cathy Doherty, Senior Vice President, Clinical Franchises, and Executive Co-Sponsor of the Empowering Better Health Award.”

***Based on 2012 consumer survey

Read More

Quest Diagnostics and CDC Expand Public Health Collaboration to Improve Hepatitis Diagnosis and Treatment 01-28-2015

Multi-year fee-based contract for Quest's test data and analytics expertise aims to reveal insights from national testing trends to promote guideline-based care and better outcomes for 4.4 million Americans with viral hepatitis

Read More

Recent Quest Diagnostics Health Trends™ Study Indicates Rise in Diabetes Diagnoses

May 11, 2015 - A recent Quest Diagnostics study indicated a significant rise in new diabetes cases in states that expanded Medicaid eligibility under the Affordable Care Act. The... Read full article

Quest Diagnostics Showcases Care360 EHR

MADISON, New Jersey, March 24, 2011 – Later this month, Quest Diagnostics will demonstrate how physicians can benefit from $39 billion in federal incentives by utilizing Care360™ EHR. The 12-week... Read full article

OVA1 Blood Test Detects Cancer More Accurately

OVA1 Blood Test Detects Ovarian Cancer More Accurately Than Medically Accepted CA 125 Method for Evaluating Women with Ovarian Mass

MADISON, N.J. and AUSTIN, Texas, May 12, 2011 /PRNewswire... Read full article

Quest Diagnostics Reports Strong Performance in Third Quarter 2009

- Total revenues of $1.9 billion, up 3.9%
- Diluted earnings of $1.02 per share, up 26%
- Cash flow from operations of $374 million, up 14%
- 2009 EPS outlook increased to a... Read full article

Contact Us

For more information about our products and services, or to find address, phone or email information, click here.

Take a Virtual Tour

Lab Image Gallery

 

 






  • "I have never seen such an in depth report of my health. It was awesome!"*

  • "Very impressive. I have NEVER received this kind of information in such an accessible format."*

  • "We loved looking at our lab work and told several of our friends and family how neat and user friendly it was!"*

*Based on 2010 survey.